Naujausios naujienos ir straipsniai apie genetinius tyrimus
May 30, 2026
Salk Institute. "Estrogen-related receptors could be key to treating metabolic and muscular disorders." ScienceDaily. ScienceDaily, 13 May 2025. <www.sciencedaily.com/releases/2025/05/250512165549....
May 30, 2026
Salk Institute. "Estrogen-related receptors could be key to treating metabolic and muscular disorders." ScienceDaily. ScienceDaily, 13 May 2025. <www.sciencedaily.com/releases/2025/05/250512165549....
May 30, 2026
Researchers have identified a potential link between estrogen-related receptors and various metabolic and muscular disorders. Further investigation of these receptors may lead to new treatment options for these conditions.
May 30, 2026
Scientists have conducted a study to assess the effectiveness of an anti-aging cream. The results suggest that this topical treatment may possess anti-aging properties.
May 30, 2026
Researchers have developed a topical cream that demonstrates significant anti-aging effects. The formula's efficacy was assessed through a series of laboratory experiments and preliminary human trials.
May 30, 2026
Researchers have conducted a study to evaluate the effectiveness of an anti-aging cream, with promising results indicating its potential as a viable treatment option. The cream's mechanism and benefits are explored in this investigation.
May 29, 2026
Researchers have developed a gene-based blood test that may detect early signs of melanoma recurrence in patients who have undergone treatment. This innovative diagnostic tool has the potential to improve patient outcomes and reduce mortality rates.
May 29, 2026
Researchers at NYU Langone Health have developed a gene-based blood test that may help detect early signs of melanoma recurrence. This innovative test uses genetic markers to identify potential cancer returns, potentially improving patient outcomes.
May 29, 2026
Researchers from NYU Langone Health and the NYU Grossman School of Medicine have developed a gene-based blood test that may help detect early signs of melanoma recurrence. This non-invasive diagnostic tool has the potential to improve patient outcomes by enabling timely intervention.
